Group Urges Specialized-Drug Imports Under New Philippines Law
This article was originally published in PharmAsia News
The head of a Philippines drugstore association is urging the government to use the new Cheaper Medicines Act to focus on importing more specialized drugs not easily found in the country. The president of the Drugstores Association of the Philippines cited less-common drugs for treating cancer, which she said should be encouraged for patients who cannot afford more-expensive treatments. The Department of Health has said such expensive drugs may be included in the new law's maximum retail price provision if competition is considered unlikely to drive down prices. (Click here for more
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
With COVID-19 continuing to wreak havoc in the EU just as throughout the globe, the European Commission is proposing new measures that will impact antigen test availability and use
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.